Cycle Pharmaceuticals appoints Denise Moody as Chief Operating Officer
June 28th 2021
Cycle Pharmaceuticals appoints Denise Moody as Chief Operating Officer
Cambridge, U.K., 28 June 2021 – Cycle Pharmaceuticals Ltd announced today the appointment of Denise Moody as Chief Operating Officer (COO).
Denise Moody brings to Cycle more than 30 years’ experience in the healthcare sector where she has built and led highly successful project teams in R&D, post-approval and legacy transfer projects with values in excess of $100 million.
“I am delighted to welcome Denise as our Chief Operating Officer” said Antonio Benedetti, Cycle’s CEO. “Looking at our robust pipeline, our global operations and our growth plans, execution is of the essence. Denise’s leadership and extensive knowledge of the industry will be key factors for Cycle’s success.”
As COO, Ms Moody will lead Cycle’s key functions of Product Development, Regulatory Affairs, Quality, Supply Chain and Programme Management.
“I am excited to be working again with Antonio and the Cycle team. Cycle is entering in a new, exciting phase, expanding in all directions. These are the challenges I like. I will work alongside the leadership team to build for Cycle and its patients the brightest future.”
In addition to her recent role at AstraZeneca, Ms Moody has held previous roles in various Pharmaceutical companies including Roche, Bayer, Hexal, Actavis and served for 5 years at PPD, one of the largest global Clinical Research Organisations, setting up their Functional Service Partnership (FSP) division.
GL-CC-2100006 (June 2021)